Malbinder Fagura
Global Transforming Care Director Attr (Amyloid Transthyretin) @AstraZeneca
Signup · Get unlimited contacts
WORK HISTORY
Global Transforming Care Director Attr (Amyloid Transthyretin) @AstraZeneca
Cambridge, GB
EDUCATION
University of Liverpool
BSc (Hons), Pharmacology
SKILLS
ABOUT MALBINDER FAGURA
I am passionate about leading purpose-driven partnerships with healthcare systems to redesign care pathways—reducing time to diagnosis and tackling healthcare inequities at scale.Throughout my career, I’ve worked with clinical and academic partners to co-create and implement innovative, evidence-based models of care that drive systemic change. These initiatives have not only improved patient outcomes but also enabled the spread and scale of best practices across populations.Recent highlights include- OPERA Project with the University of Glasgow – Delivered AI-assisted echocardiography to reduce waiting times from 12 months to under 6 weeks- England’s First Community-Based Heart & Lung Screening Hub – In collaboration with Everton in the Community, we deployed AI-assisted echocardiography and spirometry in a clinical setting, earning the HSJ 2025 Partnership Award for Most Impactful Partnership in Preventative Healthcare, and a Highly Commended mention for improving care for people with long-term conditions.Currently, I’m focused on transforming global care for cardiac amyloidosis, co-leading the global ACT on Amyloidosis programme to enable earlier diagnosis and better outcomes for patients worldwide.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.